August
Lilly's Strattera patent upheld in US
The US court of appeals has upheld the validity of Eli Lilly & Company's patent for ADHD drug Strattera
01 Aug 2011
Lilly/Lupin Indian diabetes partnership
Eli Lilly & Company has entered into a deal with India-based pharmaceutical firm Lupin to market Lilly's Huminsulin range of products for people with diabetes in India and Nepal
01 Aug 2011
MSD to cut 12,000 jobs worldwide
MSD has said it expects to reduce its global workforce by 12 to 13 per cent before the end of 2015 in the pharmaceutical company’s financial results for the second quarter of 2011
01 Aug 2011
Amgen posts decrease in earnings
Amgen's second quarter financial results hit by US healthcare reform fees
01 Aug 2011
Astellas Pharma sees drop in Q2 income
Astellas reports a fall in income for the second quarter of 2011, as R&D and administrative expenses rise
01 Aug 2011
EU approval for Teva's contraceptive Zoely
Teva's new combined oral contraceptive Zoely has gained approval from the European Medicines Agency (EMA) for launch in the EU
02 Aug 2011
Lipitor losses affect Pfizer's Q2 sales
Pfizer has reported a minor decrease in revenue in its financial results for the second quarter of 2011 with the pharmaceutical firm feeling the first effects of generic competition for cholesterol-lowering drug Lipitor
02 Aug 2011
Teva's MS drug disappoints in trial
Teva Pharmaceutical Industries has said its oral MS drug laquinimod has failed to reach its primary endpoint in a phase III trial but the company still plans regulatory submissions in the EU and US
02 Aug 2011
MSD launches hepatitis C drug Victrelis in UK
MSD today launched chronic hepatitis C treatment Victrelis in the UK
02 Aug 2011
Mark Sneff named VP, HR, at Premier Research Group
Mark P Sneff has been appointed vice president, human resources at Premier Research Group in Philadelphia
02 Aug 2011